BRPI0810171A2 - Método para o aumento da secreção de insulina - Google Patents

Método para o aumento da secreção de insulina

Info

Publication number: BRPI0810171A2
Authority: BR; Brazil
Prior art keywords: insulin secretion; increasing insulin; increasing; secretion; insulin
Prior art date: 2007-04-12

Application number

BRPI0810171-0A2A

Other languages

English (en)

Inventor

Orlando De Souza

Luiz Belardinelli

John Shryock

Kwan Leung

Dewan Zeng

Original Assignee

Cv Therapeutics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-04-12

Filing date

2008-04-11

Publication date

2014-12-30

2008-04-11 Application filed by Cv Therapeutics Inc filed Critical Cv Therapeutics Inc

2014-12-30 Publication of BRPI0810171A2 publication Critical patent/BRPI0810171A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI0810171-0A2A 2007-04-12 2008-04-11 Método para o aumento da secreção de insulina BRPI0810171A2 (pt)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US91145707P	2007-04-12	2007-04-12
US97700907P	2007-10-02	2007-10-02
US2622308P	2008-02-05	2008-02-05
PCT/US2008/060090 WO2008128086A1 (en)	2007-04-12	2008-04-11	Ranolazine for enhancing insulin secretion

Publications (1)

Publication Number	Publication Date
BRPI0810171A2 true BRPI0810171A2 (pt)	2014-12-30

Family

ID=39598448

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0810171-0A2A BRPI0810171A2 (pt)	2007-04-12	2008-04-11	Método para o aumento da secreção de insulina

Country Status (10)

Country	Link
US (2)	US20080255031A1 (pt)
EP (1)	EP2139480A1 (pt)
JP (1)	JP2010523713A (pt)
KR (1)	KR20100015685A (pt)
AU (1)	AU2008240202A1 (pt)
BR (1)	BRPI0810171A2 (pt)
CA (1)	CA2681444A1 (pt)
IL (1)	IL201071A0 (pt)
MX (1)	MX2009010895A (pt)
WO (1)	WO2008128086A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20090012103A1 (en)	2007-07-05	2009-01-08	Matthew Abelman	Substituted heterocyclic compounds
KR20110013348A (ko) *	2008-02-06	2011-02-09	길리애드 사이언시즈, 인코포레이티드	통증 치료를 위한 라놀라진의 용도
EP2515880B1 (en) *	2009-05-28	2019-11-27	Lupin Limited	Novel pharmaceutical compositions of ranolazine
MX2012003362A (es) *	2009-09-25	2012-06-27	Lupin Ltd	Composicion de liberación sostenida de ranolazina.
US10940159B2 (en)	2010-07-09	2021-03-09	James Trinca Green	Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin
PL2707361T3 (pl)	2011-05-10	2018-01-31	Gilead Sciences Inc	Skondensowane związki heterocykliczne stosowane jako modulatory kanału sodowego
TWI622583B (zh)	2011-07-01	2018-05-01	基利科學股份有限公司	作為離子通道調節劑之稠合雜環化合物
NO3175985T3 (pt)	2011-07-01	2018-04-28
GR1010510B (el) *	2022-06-07	2023-07-20	Ελπεν Α.Ε. Φαρμακευτικη Βιομηχανια,	Στερεες φαρμακοτεχνικες μορφες παρατεταμενης αποδεσμευσης ρανολαζινης
WO2025252860A1 (en) *	2024-06-04	2025-12-11	Celex Oncology Innovations Limited	Ranolazine enantiomer for use in cancer treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002007716A2 (en) *	2000-07-21	2002-01-31	Cv Therapeutics, Inc.	Method for treating angina
EP1505977B1 (en) *	2002-05-21	2014-09-10	Gilead Sciences, Inc.	Administration of a partial fatty acid oxidation inhibitor such as ranolazine for the treatment of diabetes
CA2593593A1 (en) *	2005-01-06	2006-07-13	Cv Therapeutics, Inc.	Sustained release pharmaceutical formulations comprising ranolazine

2008
- 2008-04-11 US US12/101,669 patent/US20080255031A1/en not_active Abandoned
- 2008-04-11 KR KR1020097021762A patent/KR20100015685A/ko not_active Withdrawn
- 2008-04-11 EP EP08745651A patent/EP2139480A1/en not_active Withdrawn
- 2008-04-11 AU AU2008240202A patent/AU2008240202A1/en not_active Abandoned
- 2008-04-11 WO PCT/US2008/060090 patent/WO2008128086A1/en not_active Ceased
- 2008-04-11 BR BRPI0810171-0A2A patent/BRPI0810171A2/pt not_active Application Discontinuation
- 2008-04-11 CA CA002681444A patent/CA2681444A1/en not_active Abandoned
- 2008-04-11 JP JP2010503245A patent/JP2010523713A/ja not_active Withdrawn
- 2008-04-11 MX MX2009010895A patent/MX2009010895A/es not_active Application Discontinuation
2009
- 2009-09-21 IL IL201071A patent/IL201071A0/en unknown
2010
- 2010-01-04 US US12/651,891 patent/US20100105695A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20100105695A1 (en)	2010-04-29
MX2009010895A (es)	2009-10-26
AU2008240202A1 (en)	2008-10-23
EP2139480A1 (en)	2010-01-06
US20080255031A1 (en)	2008-10-16
KR20100015685A (ko)	2010-02-12
JP2010523713A (ja)	2010-07-15
IL201071A0 (en)	2010-05-17
CA2681444A1 (en)	2008-10-23
WO2008128086A1 (en)	2008-10-23

Publication	Publication Date	Title
NO2024044I1 (no)	2024-10-08	Insulin icodec
BRPI0910282A2 (pt)	2015-09-01	Composto oxadiazo-antraceno para o tratamento de diabetes
BRPI0810171A2 (pt)	2014-12-30	Método para o aumento da secreção de insulina
BRPI0814359A2 (pt)	2015-08-11	Método
BRPI0817226A2 (pt)	2015-06-16	Método
BRPI0916152A2 (pt)	2015-11-10	aparelho para via aérea melhorado
BRPI0817726A2 (pt)	2015-03-31	Método
BRPI0819127A2 (pt)	2015-05-05	Método para cimentar.
BRPI0821158A2 (pt)	2015-06-16	Método para fazer lentes de contato
BRPI0912384A2 (pt)	2015-10-13	composição, e, método para preparar uma composição
BRPI0812744A2 (pt)	2014-12-23	Métodos para melhoramento molecular direcionado por sequência
BRPI0911077A2 (pt)	2015-12-29	método para tratamento de biomassa
BRPI0815550A2 (pt)	2015-02-18	Método para estabilizar fenilefrina
FI20075721A0 (fi)	2007-10-11	Menetelmä pyrolysoinnin toteuttamiseksi
BRPI0811786A2 (pt)	2014-11-11	Acionador para inalador dosimetrado
BRPI0822730A2 (pt)	2015-07-14	Método para comutação ininterrupta
BR112012007880A2 (pt)	2016-03-15	aparelho de fabricação para um membro dobrado, método para fabricar um membro dobrado e membro dobrado
BRPI0813670A2 (pt)	2014-12-30	Compostos para tratamento
BRPI0922490A2 (pt)	2015-08-04	Método para produção de beta-santaleno
BRPI0906491A2 (pt)	2015-07-14	Método para reconstrução de imagem.
FI20075505A0 (fi)	2007-07-04	Menetelmä silmälasien valmistamiseksi
BRPI0813858A2 (pt)	2015-01-06	Método para produzir peptídeo
BRPI0812741A2 (pt)	2014-12-23	Método para separação de glóbulos
BRPI0907643A2 (pt)	2015-07-21	Dispositivo de irrigação, método para fabricar dito dispositivo, e meios por conseguinte
BRPI0810416A2 (pt)	2014-10-14	Método de hidroformação

Legal Events

Date	Code	Title	Description
2015-06-02	B11A	Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
2015-09-01	B11Y	Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]